<DOC>
	<DOCNO>NCT01657500</DOCNO>
	<brief_summary>The purpose study compare success store donor cornea Optisol GS , current standard vs. store donor cornea Life4°C , new solution . The donor cornea use EK provide eye bank store either Optisol GS solution Life 4°C solution . At 6 month , doctor determine whether comparable difference cell loss graft clarity two donor cornea .</brief_summary>
	<brief_title>Life 4°C Versus Optisol Corneal Storage Media</brief_title>
	<detailed_description>1 . Purpose/ Specific Aims The purpose study compare success store donor cornea Optisol GS , current standard solution donor cornea store prior surgery versus store donor cornea Life 4°C , new solution . Laboratory test lead recent approval new storage solution Food Drug Administration suggest solution may support health endothelial cell well Optisol GS . While extensive vitro ex vivo data regard Life 4°C transport chamber , short long term vivo study examine performance clinically relationship performance Optisol GS transport chamber . This study design examine question . 1.1 STUDY OBJECTIVES Primary objective : To determine whether endothelial cell loss post EK comparable 6 month postoperatively donor cornea preserve Life 4°C vs. Optisol GS corneal storage medium Secondary objective : To determine whether graft clarity post EK comparable 6 month postoperatively donor cornea preserve Life 4°C versus Optisol GS corneal storage medium 2 . Background Significance Currently estimate Eye Bank Association America ( EBAA ) 3500 5000 Americans wait average 1-2 month undergo penetrate endothelial keratoplasty . The situation worldwide considerably complex , availability tissue much limit . In view shortage tissue , much research undertaken view towards prolong donor storage time yet maintain viable endothelium , crucial successful transplantation . Extended preservation time transform corneal transplantation surgery elective procedure facilitate availability available donor tissue . However , corneal preservation involve many factor addition simply increase length donor storage time . The functional status endothelium , epithelium sustain corneal deturgescence corneal preservation great clinical importance contribute primarily success surgical outcome . Other area concern address development complete corneal preservation medium include enhancement corneal wound heal reduction elimination normal progressive loss endothelial cell post keratoplasty . Preservation exist endothelial cell corneal preservation important endothelial cell continue lose penetrating keratoplasty faster rate normal aging1 . Timely adequate healing corneal tissue require restore visual acuity . The current `` gold standard '' 4°C corneal preservation medium Optisol GS ( Bausch &amp; Lomb Surgical , Inc. ) . This improved formulation Optisol 2 ( Chiron Vision , Irvine , CA , U.S.A. ) modify addition 200 µg/ml streptomycin sulfate . Optisol preserve corneal endothelium well DexSol ( Chiron Vision , Irvine , CA , U.S.A. ) , previous widely use corneal preservation medium , good prevent stromal swell storage 2-5 . The addition streptomycin gentamicin corneal preservation medium effective resistant strain bacteria6 . Optisol GS exhibit improved antibacterial activity without increase toxicity endothelium7-8 . In vitro study Optisol GS store human cornea conclude storage time 4°C limited inability preserve corneal epithelium great 1 week , although 84 % endothelium deem viable three week storage 9,10 . A clinical study find probability epithelial defect 1 day penetrate keratoplasty increase increase storage time Optisol GS11 . Optisol GS chondroitin sulfate contain medium supplement dextran , additional antioxidant , energy source nutritive substrates12 . These component address understand cornea still metabolically active low storage temperature . The composition synthetic medium must address increase stromal hydration occurs increase preservation time reduced temperature . In progression intermediate-term corneal preservation medium development , dextran , osmotic agent , add effort reduce intraoperative rebound swell associate chondroitin sulfate contain medium . Chondroitin sulfate dextran assist prevention stromal hydration increase colloidal osmotic pressure aqueous environment surround store cornea . Sustained corneal deturgescence corneal preservation great clinical importance , reduce handle suture problem encounter transplant surgeon , thus reduce risk graft failure A superior corneal preservation medium would maintain cellular viability lengthen current storage time efficient use donor tissue , prevent stromal swell facilitate keratoplasty , eliminate suppress microbiologic growth prevent rare catastrophic endophthalmitis . 2.1 INVESTIGATIONAL AGENT Life 4°C FDA approve , new advanced corneal preservation medium ( 30 ml ) storage human cornea suitable keratoplasty 14 day refrigeration ( 2-8°C ) . Life 4°C sterile , non-pyrogenic , advanced buffer corneal preservation medium supplement chondroitin sulfate ( membrane stabilizer ) , recombinant human insulin ( cell metabolism enhancer ) , Dextran ( osmotic agent ) , glutathione ( antioxidant , free-radical scavenger , enzyme cofactor ) , stabilize L-glutamine , ATP precursor , nutrient cell supplement , amino acid , vitamin , trace element , gentamycin , streptomycin phenol red ( pH indicator ) . Life 4°C formulate use full extent corneal storage time , prevent stromal swelling , maintain corneal epithelium provide optimum endothelial cell preservation . In addition , TRANSEND new corneal storage , view transport system . It design performance meet challenge extend storage , specular microscopy shipping . TRANSEND view chamber design accommodate large scleral rim need newest surgical procedure . The increased medium volume ( 30 ml ) great fluid flow cornea reduce metabolic waste build-up , important cellular health . Increased medium volume result excellent corneal preservation minimal corneal swell storage . The TRANSEND view chamber utilizes top seal o-ring side seal leak-proof performance . The cornea hold securely storage , specular microscopy shipping . The view chamber gamma irradiate , therefore ETO residual . The use new tamper seal eliminate use high temperature heat seal . The outer ship container allow inner view chamber arrive dry secure surgeon .</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Gentamicins</mesh_term>
	<mesh_term>Dextrans</mesh_term>
	<criteria>1 . Subjects undergo EK FECD . 2 . Age range 3085 year minimum life expectancy least 1 year 3 . Willingness return study site 1 month , 3 month , 6 month complete study procedure 4 . Permissible EK procedure preoperative diagnosis Pseudophakic FECD posterior capsule support suturefixated posterior chamber intraocular lens ( IOL ) Phakic FECD EK , phacoemulsification posterior chamber IOL phakic FECD cataract 5 . Stromal vascularization acceptable 6 . Controlled glaucoma medication and/or previous trabeculectomy laser trabeculoplasty acceptable 1 . Since EK suitable corneal condition endothelial dysfunction , corneal condition associate endothelial failure manage PKP exclude ( e.g . keratoconus , stromal dystrophy , traumatic corneal scar ) . Other exclusion include : Other primary endothelial dysfunction condition include pseudophakic bullous keratopathy due FECD , posterior polymorphous corneal dystrophy congenital hereditary corneal dystrophy Pseudophakic FECD open loop anterior chamber IOL Previous fail keratoplasty , either EK PKP Central subepithelial stromal scar detect preoperatively could impact graft clarity assessment Anterior peripheral anterior synechiae Uncontrolled glaucoma &gt; 25 Hg without prior filter surgery shunt placement . Controlled glaucoma tube shunt placement . Uncontrolled Uveitis Fellow eye visual acuity &lt; 20/200 Fellow eye already include study</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>endothelial keratoplasty</keyword>
</DOC>